Aurion Biotech Completes Enrollment In Pivotal Astra Phase 3 Study, Advancing Aurn001 Toward Potential New Treatment For Corneal Edema Secondary To Corneal Endothelial Dysfunction
Aurion Biotech Inc (AURN.N)
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.